[논문]Advantages and disadvantages of targeted therapy in patients with rheumatoid arthritis

Sung, Yoon-Kyoung

doi:10.5124/jkma.2021.64.2.90

Advantages and disadvantages of targeted therapy in patients with rheumatoid arthritis 원문보기

JKMA : Journal of the Korean Medical Association = 대한의사협회지, v.64 no.2, 2021년, pp.90 - 93

Sung, Yoon-Kyoung

Abstract ▼ AI-Helper

With the recent understanding of the pathogenesis of rheumatoid arthritis at the cellular and molecular levels, as well as the rapid progress of biotechnology, targeted therapies have been developed and used since 2000. Starting with the development of biological products, which were early targeted therapeutics, small molecule inhibitors have recently been developed that target Janus kinase, a signaling molecule for intracellular inflammatory cytokines. The use of targeted therapies has dramatically improved the treatment outcomes and prognosis of rheumatoid arthritis. However, there is still concern around long-term safety of drugs and the rise in the economic burden on individuals and society due to the high price of biological products and Janus kinase inhibitors. To use those targeted therapeutics efficiently to ensure that suitable patients can fully benefit, both a multidisciplinary approach and the collaboration of experts are required. From the patient’s perspective, it is necessary to develop a system of patient’ education and to support shared decision-making between patients and physician. From the perspective of medical personnel, it is necessary to ensure the autonomy of experts. In addition, from a socio-economic viewpoint, it is necessary to adjust drug prices and review biosimilar utilization plans to reduce medical costs. The expanding use of these drugs among rheumatoid arthritis patients will eventually lead to greater social benefits by reducing disability among patients, facilitating their economic activity, and improving their quality of life. However, it is time to discuss their appropriate selection and safe long-term use with well-trained experts.

참고문헌 (12)

Scott, D.L., Wolfe, F., Huizinga, T.W.. Rheumatoid arthritis. The Lancet, vol.376, no.9746, 1094-1108.

상세보기
Smolen, Josef S, Goncalves, Joao, Quinn, Mark, Benedetti, Fabrizio, Lee, Jake Yongkwon. Era of biosimilars in rheumatology: reshaping the healthcare environment. RMD open, vol.5, no.1, e000900-.

상세보기
Sung, Yoon-Kyoung, Jung, Sun-Young, Kim, Hyoungyoung, Choi, Seongmi, Im, Seul Gi, Lee, Yu Sang, Jang, Eun Jin, Cho, Soo-Kyung. Factors for starting biosimilar TNF inhibitors in patients with rheumatic diseases in the real world. PloS one, vol.15, no.1, e0227960-.

상세보기
Singh, Jasvinder A., Saag, Kenneth G., Bridges Jr., S. Louis, Akl, Elie A., Bannuru, Raveendhara R., Sullivan, Matthew C., Vaysbrot, Elizaveta, McNaughton, Christine, Osani, Mikala, Shmerling, Robert H., Curtis, Jeffrey R., Furst, Daniel E., Parks, Deborah, Kavanaugh, Arthur, O'Dell, James, King, Charles, Leong, Amye, Matteson, Eric L., Schousboe, John T., Drevlow, Barbara, Ginsberg, Seth, Grober, James, St.Clair, E. William, Tindall, Elizabeth, Miller, Amy S., McAlindon, Timothy. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis care & research, vol.68, no.1, 1-25.

상세보기
Smolen, Josef S, Landewé, Robert B M, Bijlsma, Johannes W J, Burmester, Gerd R, Dougados, Maxime, Kerschbaumer, Andreas, McInnes, Iain B, Sepriano, Alexandre, van Vollenhoven, Ronald F, de Wit, Maarten, Aletaha, Daniel, Aringer, Martin, Askling, John, Balsa, Alejandro, Boers, Maarten, den Broeder, Alfons A, Buch, Maya H, Buttgereit, Frank, Caporali, Roberto, Cardiel, Mario Humberto, De Cock, Diederik, Codreanu, Catalin, Cutolo, Maurizio, Edwards, Christopher John, van Eijk-Hustings, Yvonne, Emery, Paul, Finckh, Axel, Gossec, Laure, Gottenberg, Jacques-Eric, Hetland, Merete Lund, Huizinga, Tom W J, Koloumas, Marios, Li, Zhanguo, Mariette, Xavier, Mu¨ller-Ladner, Ulf, Mysler, Eduardo F, da Silva, Jose A P, Poór, Gyula, Pope, Janet E, Rubbert-Roth, Andrea, Ruyssen-Witrand, Adeline, Saag, Kenneth G, Strangfeld, Anja, Takeuchi, Tsutomu, Voshaar, Marieke, Westhovens, René, van der Heijde, Désirée. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the rheumatic diseases : the official journal, vol.79, no.6, 685-699.

상세보기
Park, Eun-Jung, Kim, Hyungjin, Jung, Seung Min, Sung, Yoon-Kyoung, Baek, Han Joo, Lee, Jisoo. The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus. Journal of rheumatic diseases : JRD, vol.27, no.1, 4-.

상세보기
Cho, Soo-Kyung, Sung, Yoon-Kyoung. Treatment strategy for patients with rheumatoid arthritis. JKMA : Journal of the Korean Medical Association = 대한의사협회지, vol.63, no.7, 422-430.

상세보기
Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers Seong 706 2007
Lee, Seung Heon. Diagnosis and Treatment of Latent Tuberculosis Infection: The Updated 2017 Korean Guidelines. The Korean journal of medicine = 대한내과학회지, vol.93, no.6, 509-517.

상세보기
Lee, Eun Bong. Small Molecule Inhibitors in Rheumatoid Arthritis. Journal of rheumatic diseases : JRD, vol.19, no.3, 118-.

상세보기
The global use of medicine in 2019 and outlook to 2023 [Internet] 2019
Hakim, Aaron, Ross, Joseph S.. Obstacles to the Adoption of Biosimilars for Chronic Diseases. JAMA : the journal of the American Medical Association, vol.317, no.21, 2163-.

상세보기

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Advantages and disadvantages of targeted therapy in patients with rheumatoid arthritis 원문보기

Abstract ▼ AI-Helper

참고문헌 (12)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트